Anlon Healthcare Ltd

NSE: AHCL BSE: 544497Pharma

Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).[1]

₹13.3

52W: ₹8.7 — ₹17.3

PE 25.1 · Book ₹4.03 · +230% vs book

Market Cap₹708 Cr

Stock P/E25.1Price to Earnings

ROCE24.8%Return on Capital

ROE40.4%Return on Equity

Div. Yield0%Face Value ₹2

Strengths

+Company has reduced debt.
+Company has a good return on equity (ROE) track record: 3 Years ROE 51.9%

Weaknesses

−Though the company is reporting repeated profits, it is not paying out dividend
−Company might be capitalizing the interest cost
−Company has high debtors of 228 days.

Shareholding Pattern

Promoters52.68%

FIIs0.32%

DIIs4.6%

Public42.4%

Category	Sep 2025	Dec 2025	Mar 2026
Promoters	52.68%	52.68%	52.68%
FIIs	0%	0.23%▲0.2	0.32%▲0.1
DIIs	2.83%	4.49%▲1.7	4.6%▲0.1
Public	44.49%	42.6%▼1.9	42.4%▼0.2

Financial Statements

Metric	Jun 2024	Sep 2024	Dec 2024	Jun 2025	Sep 2025	Dec 2025
Sales	37.83	24.17	9.36	33.3	52.2	35.58
Expenses	30.98	16.65	8.78	27.06	38.46	23.23
Operating Profit	6.85	7.52	0.58	6.24	13.74	12.35
OPM %	18.11%	31.11%	6.2%	18.74%	26.32%	34.71%
Net Profit	4.54	2.59	-2.49	3.55	9.32	5.15
EPS ₹	0.28	0.06	-0.06	0.09	0.18	0.1

AI Insights

Revenue Trend

Mar 2025 revenue at ₹120Cr, up 81.8% YoY. OPM at 27%.

Debt Position

Borrowings at ₹58Cr. Debt-to-equity ratio: 0.36x. Healthy balance sheet.

Margin & Efficiency

ROCE improving from 0% (Mar 2021) to 25% (Mar 2025). Working capital days: 292.

Valuation

PE 25.1x with 24.8% ROCE. Price is 230% above book value of ₹4.03. Dividend yield: 0%.